Hagemann Jan H, Haegele Holger, Müller Susanna, Anders Hans-Joachim
Nephrologisches Zentrum, Medizinische Klinik und Poliklinik IV der Ludwig-Maximilians Universität, München 80336, Germany.
Int J Mol Sci. 2013 May 28;14(6):11319-46. doi: 10.3390/ijms140611319.
Are there common pathways underlying the broad spectrum of tissue pathologies that develop upon injuries and from subsequent tissue remodeling? Here, we explain the pathophysiological impact of a set of evolutionary conserved danger control programs for tissue pathology. These programs date back to the survival benefits of the first multicellular organisms upon traumatic injuries by launching a series of danger control responses, i.e., 1. Haemostasis, or clotting to control bleeding; 2. Host defense, to control pathogen entry and spreading; 3. Re-epithelialisation, to recover barrier functions; and 4. Mesenchymal, to repair to regain tissue stability. Taking kidney pathology as an example, we discuss how clotting, inflammation, epithelial healing, and fibrosis/sclerosis determine the spectrum of kidney pathology, especially when they are insufficiently activated or present in an overshooting and deregulated manner. Understanding the evolutionary benefits of these response programs may refine the search for novel therapeutic targets to limit organ dysfunction in acute injuries and in progressive chronic tissue remodeling.
在损伤后发生的广泛组织病理学以及随后的组织重塑过程中,是否存在共同的潜在途径?在此,我们解释了一组进化保守的危险控制程序对组织病理学的病理生理影响。这些程序可追溯到第一批多细胞生物在遭受创伤性损伤时通过启动一系列危险控制反应而获得的生存益处,即:1. 止血,或凝血以控制出血;2. 宿主防御,以控制病原体的侵入和传播;3. 重新上皮化,以恢复屏障功能;4. 间充质反应,以修复并恢复组织稳定性。以肾脏病理学为例,我们讨论凝血、炎症、上皮愈合和纤维化/硬化如何决定肾脏病理学的范围,特别是当它们激活不足或以过度和失调的方式出现时。了解这些反应程序的进化益处可能会优化对新型治疗靶点的寻找,以限制急性损伤和进行性慢性组织重塑中的器官功能障碍。